Literature DB >> 23356270

Role of p90(RSK) in regulating the Crabtree effect: implications for cancer.

Emily K Redman1, Paul S Brookes, Marcin K Karcz.   

Abstract

High glucose inhibits mitochondrial respiration, known as the 'Crabtree effect', in cancer cells and possibly other cell types. The upstream pathways regulating this phenomenon are poorly understood. In diabetes, where glucose levels are elevated, the p90(RSK) (p90 ribosomal S6 kinase) has received much attention as a potential upstream mediator of the effects of high glucose. Evidence is also emerging that p90(RSK) may play a role in cancer cell signalling, although the role of p90(RSK) in regulating cancer cell metabolism is unclear. In the present paper, we provide an overview of the Crabtree effect and its relationship to mitochondrial metabolism. Furthermore, preliminary data are presented suggesting a role for p90(RSK) and its upstream components, the ERK (extracellular-signal-regulated kinase) family of MAPKs (mitogen-activated protein kinases), in the Crabtree effect.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23356270      PMCID: PMC4030437          DOI: 10.1042/BST20120277

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  35 in total

1.  Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling.

Authors:  N D Marchenko; A Zaika; U M Moll
Journal:  J Biol Chem       Date:  2000-05-26       Impact factor: 5.157

2.  Contribution of the ERK5/MEK5 pathway to Ras/Raf signaling and growth control.

Authors:  J M English; G Pearson; T Hockenberry; L Shivakumar; M A White; M H Cobb
Journal:  J Biol Chem       Date:  1999-10-29       Impact factor: 5.157

3.  Biochemistry and molecular cell biology of diabetic complications.

Authors:  M Brownlee
Journal:  Nature       Date:  2001-12-13       Impact factor: 49.962

4.  On respiratory impairment in cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-08-10       Impact factor: 47.728

5.  Observations on the carbohydrate metabolism of tumours.

Authors:  H G Crabtree
Journal:  Biochem J       Date:  1929       Impact factor: 3.857

6.  Specificity and mechanism of action of some commonly used protein kinase inhibitors.

Authors:  S P Davies; H Reddy; M Caivano; P Cohen
Journal:  Biochem J       Date:  2000-10-01       Impact factor: 3.857

7.  Erk5 participates in neuregulin signal transduction and is constitutively active in breast cancer cells overexpressing ErbB2.

Authors:  Azucena Esparís-Ogando; Elena Díaz-Rodríguez; Juan Carlos Montero; Laura Yuste; Piero Crespo; Atanasio Pandiella
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

Review 8.  The Warburg and Crabtree effects: On the origin of cancer cell energy metabolism and of yeast glucose repression.

Authors:  Rodrigo Diaz-Ruiz; Michel Rigoulet; Anne Devin
Journal:  Biochim Biophys Acta       Date:  2010-09-08

9.  ERK5 MAPK regulates embryonic angiogenesis and acts as a hypoxia-sensitive repressor of vascular endothelial growth factor expression.

Authors:  Sue J Sohn; Brieana K Sarvis; Dragana Cado; Astar Winoto
Journal:  J Biol Chem       Date:  2002-09-06       Impact factor: 5.157

10.  Identification of mitogen-activated protein kinase kinase as a chemoresistant pathway in MCF-7 cells by using gene expression microarray.

Authors:  Christopher B Weldon; Ali B Scandurro; Kevin W Rolfe; John L Clayton; Steven Elliott; Nancy N Butler; Lilia I Melnik; Jawed Alam; John A McLachlan; Bernard M Jaffe; Barbara S Beckman; Matthew E Burow
Journal:  Surgery       Date:  2002-08       Impact factor: 3.982

View more
  8 in total

Review 1.  MYC and mitochondrial biogenesis.

Authors:  Fionnuala Morrish; David Hockenbery
Journal:  Cold Spring Harb Perspect Med       Date:  2014-05-01       Impact factor: 6.915

2.  Dihydroartemisinin inhibits the Raf/ERK/MEK and PI3K/AKT pathways in glioma cells.

Authors:  Wei DU; Changhe Pang; Yake Xue; Qingjun Zhang; Xinting Wei
Journal:  Oncol Lett       Date:  2015-09-15       Impact factor: 2.967

Review 3.  Connexins and Glucose Metabolism in Cancer.

Authors:  Jennifer C Jones; Thomas M Bodenstine
Journal:  Int J Mol Sci       Date:  2022-09-05       Impact factor: 6.208

Review 4.  Cancer as a metabolic disease: implications for novel therapeutics.

Authors:  Thomas N Seyfried; Roberto E Flores; Angela M Poff; Dominic P D'Agostino
Journal:  Carcinogenesis       Date:  2013-12-16       Impact factor: 4.944

5.  Role of MEK-ERK signaling mediated adhesion of glioma cells to extra-cellular matrix: Possible implication on migration and proliferation.

Authors:  Palaniswamy Ramaswamy; Nandakumar Dalavaikodihalli Nanjaiah; Monjuri Borkotokey
Journal:  Ann Neurosci       Date:  2019-04-01

6.  Double-Targeted Knockdown of miR-21 and CXCR4 Inhibits Malignant Glioma Progression by Suppression of the PI3K/AKT and Raf/MEK/ERK Pathways.

Authors:  Feijiao Liu; Bo Yang
Journal:  Biomed Res Int       Date:  2020-10-15       Impact factor: 3.411

7.  RSK1 vs. RSK2 Inhibitory Activity of the Marine β-Carboline Alkaloid Manzamine A: A Biochemical, Cervical Cancer Protein Expression, and Computational Study.

Authors:  Alejandro M S Mayer; Mary L Hall; Joseph Lach; Jonathan Clifford; Kevin Chandrasena; Caitlin Canton; Maria Kontoyianni; Yeun-Mun Choo; Dev Karan; Mark T Hamann
Journal:  Mar Drugs       Date:  2021-09-07       Impact factor: 5.118

8.  Myricetin exerts anti-proliferative, anti-invasive, and pro-apoptotic effects on esophageal carcinoma EC9706 and KYSE30 cells via RSK2.

Authors:  Wenqiao Zang; Tao Wang; Yuanyuan Wang; Min Li; Xiaoyan Xuan; Yunyun Ma; Yuwen Du; Kangdong Liu; Ziming Dong; Guoqiang Zhao
Journal:  Tumour Biol       Date:  2014-09-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.